- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06655116
Diabetic Foot Education
The Effect of Patient Education on Foot Care Behaviour and Diabetic Foot Self-Efficacy in Individuals With Type II Diabetes: A Randomised Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Talas
-
Kayseri, Talas, Turkey, 38030
- Erciyes University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Over 18 years of age,
- Diagnosis of Type 2 DM for at least 6 months,
- Not having received planned diabetic foot training before,
- Volunteering to participate in the study,
Exclusion Criteria:
- Neuropsychiatric drug use and disease that may affect education (Dementia- Alzheimer's and Mental Retardation etc.)
- Being visually impaired,
- Hearing impairment,
- Inability to speak Turkish,
- Presence of active diabetic foot ulcer.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Control Group
|
|
|
Study Grup
|
Patients in the intervention group will be interviewed and their diabetic foot knowledge will be evaluated. During the interview, the individual's knowledge about the definition of diabetic foot, risk factors, symptoms, treatment, complications, care and prevention will be evaluated. In order to systematically plan, implement and evaluate the training to be used in the intervention, it is aimed to implement androgogical training based on the 'Interpersonal Relations Theory'. In this context, the stages in the theory will be followed as follows. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Descriptive Information Form:
Time Frame: 2 Minutes
|
The descriptive information form, which was created by the researchers by reviewing the literature, consists of 16 items in total, including seven questions about individual characteristics (age, gender, height, weight, education level, family structure, smoking) and nine questions about the disease and diabetic foot (HbA1c value, number of years of living with diabetes, treatment(s) received, history of diabetic foot).
|
2 Minutes
|
|
Diabetic Foot Self-Care Behaviour Scale
Time Frame: 5 minutes
|
The Diabetic Outpatient Self-Care Behaviour Scale was developed by Yen-Fan Chin and Tzu-Ting Huang in 2013 (Chin & Huang, 2013).
The Turkish validity and reliability study conducted by Bakır and Samancıoğlu Bağlama was published in 2021.
The scale is a five-point Likert-type scale consisting of 7 items and two sections.
The first part consists of four items including practices related to examining, washing and drying the soles of the feet and toes during the week.
The three items in the second section are related to the use of shoes and lotion.
The lowest score that can be obtained from the first section is 4 and the highest score is 20.
The lowest score that can be obtained from the second section is 3 and the highest score is 15.
The questionnaire is evaluated over the total score and the score that can be obtained varies between 7-35.
As the score obtained from the scale increases, self-care behaviour increases.
|
5 minutes
|
|
Diabetic Foot Care Self-Efficacy Scale
Time Frame: 5 minutes
|
The scale consisting of nine items is answered with an 11-digit visual scale ranging from 0-10.
In the answers, the lowest value is expressed as 'I do not consider it sufficient at all' and the highest value is expressed as 'I consider it very sufficient'.
The scale has no sub-dimensions and is evaluated on the total scale score.
The lowest score that can be obtained from the scale is 0 and the highest score is 90.
As the score obtained from the scale increases, the level of diabetic foot self-efficacy increases.
|
5 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16.10.2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Diabetic Foot Education
-
Istanbul Medeniyet UniversityCompletedDiabetic Foot, Mobile Application, Patient Education
-
Istanbul Medeniyet UniversityCompletedDiabetic Foot Ulcer | Patient Education | PechaKucha MethodTurkey
-
Okayama UniversityCompletedDiabetic Peripheral NeuropathyJapan
-
Marmara UniversityActive, not recruitingDiabetic Foot | Diabetes Mellitus Type 2Turkey
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingDiabetic Foot
-
Universitas Muhammadiyah SurakartaCompletedEffect of Diabetic Foot Exercises on Peripheral Vascular Status in Type 2 Diabetes Mellitus PatientsDiabetes Mellitus Type 2 | Peripheral Artery Disease (PAD) | Diabetic Foot Circulation ImpairmentIndonesia
-
Sanidad de Castilla y LeónCompletedImprovement of Diabetic Foot Care in Salamanca Through the Implementation of Standardized Protocols.Diabetes | Diabetic Foot | Primary Health CareSpain
-
Shanghai East HospitalFaendrich (Shanghai) Biotechnology Co., LtdNot yet recruiting
-
US Department of Veterans AffairsCompletedDiabetic Foot UlcersUnited States
-
Inonu UniversityRecruitingDiabetes Foot Care | Hemodialysis PatientTurkey (Türkiye)